Literature DB >> 22363061

Myelin loss associated with neuroinflammation in hypertensive rats.

Fakhreya Y Jalal1, Yi Yang, Jeffrey Thompson, Anita C Lopez, Gary A Rosenberg.   

Abstract

BACKGROUND AND
PURPOSE: Small vessel disease is the major cause of white matter injury in patients with vascular cognitive impairment. Matrix metalloproteinase (MMP)-mediated inflammation may be involved in the white matter damage with oligodendrocyte (Ol) death. Therefore, we used spontaneously hypertensive stroke-prone rats to study the role of neuroinflammation in white matter damage.
METHODS: Permanent unilateral carotid artery occlusion was performed at 12 weeks of age in spontaneously hypertensive stroke-prone rats. Following surgery, rats were placed on a Japanese permissive diet and received 1% NaCl in drinking water. MRI, histology, biochemistry, and ELISA characterized white matter lesions, and cognitive impairment was tested by Morris water maze.
RESULTS: White matter damage was observed 4 to 5 weeks following permanent unilateral carotid artery occlusion/Japanese permissive diet. Immunoblotting showed marked reduction in myelin basic protein and upregulation of immature Ols. Mature Ols underwent caspase-3-mediated apoptosis. Morris water maze showed cognitive impairment. Abnormally appearing vessels were observed and surrounded by inflammatory-like cells. IgG extravasation and hemorrhage, indicating blood-brain barrier (BBB) disruption, was closely associated with MMP-9 expression. Lesions in white matter showed reactive astrocytosis and activated microglia that expressed tumor necrosis factor-α. MMP-3 and MMP-9 were significantly increased, and MMP-2 was reduced in both astrocytes and Ol.
CONCLUSIONS: We found apoptosis of mature Ols with an increase in immature Ols. Increased MMP-3, MMP-9, and tumor necrosis factor-α were associated with myelin breakdown and BBB disruption. Neuroinflammation is an important factor in white matter damage and Ol death, and studies using this new model can be performed to assess agents to block inflammation.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22363061      PMCID: PMC3598597          DOI: 10.1161/STROKEAHA.111.643080

Source DB:  PubMed          Journal:  Stroke        ISSN: 0039-2499            Impact factor:   7.914


  31 in total

1.  Oligodendroglial cell death with DNA fragmentation in the white matter under chronic cerebral hypoperfusion: comparison between normotensive and spontaneously hypertensive rats.

Authors:  M Masumura; R Hata; Y Nagai; T Sawada
Journal:  Neurosci Res       Date:  2001-04       Impact factor: 3.304

Review 2.  Dementia due to subcortical ischemic vascular disease.

Authors:  H Chui
Journal:  Clin Cornerstone       Date:  2001

3.  Blood-brain barrier permeability abnormalities in vascular cognitive impairment.

Authors:  Saeid Taheri; Charles Gasparovic; Branko N Huisa; John C Adair; Elaine Edmonds; Jillian Prestopnik; Mark Grossetete; N Jon Shah; John Wills; Clifford Qualls; Gary A Rosenberg
Journal:  Stroke       Date:  2011-06-30       Impact factor: 7.914

4.  Two temporal stages of oligodendroglial response to excitotoxic lesion in the gray matter of the adult rat brain.

Authors:  N Jamin; M P Junier; G Grannec; J Cadusseau
Journal:  Exp Neurol       Date:  2001-11       Impact factor: 5.330

5.  Matrix metalloproteinase-9 mediates hypoxia-induced vascular leakage in the brain via tight junction rearrangement.

Authors:  Alexander T Bauer; Heinrich F Bürgers; Tamer Rabie; Hugo H Marti
Journal:  J Cereb Blood Flow Metab       Date:  2009-12-09       Impact factor: 6.200

6.  Effects of matrix metalloproteinase-9 gene knock-out on the proteolysis of blood-brain barrier and white matter components after cerebral ischemia.

Authors:  M Asahi; X Wang; T Mori; T Sumii; J C Jung; M A Moskowitz; M E Fini; E H Lo
Journal:  J Neurosci       Date:  2001-10-01       Impact factor: 6.167

7.  Matrix metalloproteinases are associated with increased blood-brain barrier opening in vascular cognitive impairment.

Authors:  Eduardo Candelario-Jalil; Jeffrey Thompson; Saeid Taheri; Mark Grossetete; John C Adair; Elaine Edmonds; Jillian Prestopnik; John Wills; Gary A Rosenberg
Journal:  Stroke       Date:  2011-03-31       Impact factor: 7.914

8.  White matter damage is associated with matrix metalloproteinases in vascular dementia.

Authors:  G A Rosenberg; N Sullivan; M M Esiri
Journal:  Stroke       Date:  2001-05       Impact factor: 7.914

9.  Blood-brain barrier permeability is increased in normal-appearing white matter in patients with lacunar stroke and leucoaraiosis.

Authors:  R Topakian; T R Barrick; F A Howe; H S Markus
Journal:  J Neurol Neurosurg Psychiatry       Date:  2009-08-25       Impact factor: 10.154

10.  Tissue inhibitor of metalloproteinases-3 mediates the death of immature oligodendrocytes via TNF-α/TACE in focal cerebral ischemia in mice.

Authors:  Yi Yang; Fakhreya Y Jalal; Jeffrey F Thompson; Espen J Walker; Eduardo Candelario-Jalil; Lu Li; Ross R Reichard; Chi Ben; Qing-Xiang Sang; Lee Anna Cunningham; Gary A Rosenberg
Journal:  J Neuroinflammation       Date:  2011-08-29       Impact factor: 8.322

View more
  66 in total

Review 1.  The neuropathology and cerebrovascular mechanisms of dementia.

Authors:  Limor Raz; Janice Knoefel; Kiran Bhaskar
Journal:  J Cereb Blood Flow Metab       Date:  2016-01       Impact factor: 6.200

2.  Myelin basic protein autoantibodies, white matter disease and stroke outcome.

Authors:  Dean Shibata; Kevin Cain; Patricia Tanzi; Dannielle Zierath; Kyra Becker
Journal:  J Neuroimmunol       Date:  2012-08-29       Impact factor: 3.478

Review 3.  Rodent Models of Vascular Cognitive Impairment.

Authors:  Yi Yang; Shihoko Kimura-Ohba; Jeffrey Thompson; Gary A Rosenberg
Journal:  Transl Stroke Res       Date:  2016-08-08       Impact factor: 6.829

4.  Effect of hypertension and carotid occlusion on brain parenchymal arteriole structure and reactivity.

Authors:  Julie G Sweet; Siu-Lung Chan; Marilyn J Cipolla
Journal:  J Appl Physiol (1985)       Date:  2015-08-20

Review 5.  Binswanger's disease: toward a diagnosis agreement and therapeutic approach.

Authors:  Branko N Huisa; Gary A Rosenberg
Journal:  Expert Rev Neurother       Date:  2014-09-09       Impact factor: 4.618

Review 6.  Sex differences in the immune response to experimental stroke: Implications for translational research.

Authors:  Abby L Dotson; Halina Offner
Journal:  J Neurosci Res       Date:  2017-01-02       Impact factor: 4.164

Review 7.  Understanding the role of the perivascular space in cerebral small vessel disease.

Authors:  Rosalind Brown; Helene Benveniste; Sandra E Black; Serge Charpak; Martin Dichgans; Anne Joutel; Maiken Nedergaard; Kenneth J Smith; Berislav V Zlokovic; Joanna M Wardlaw
Journal:  Cardiovasc Res       Date:  2018-09-01       Impact factor: 10.787

8.  HDAC inhibitors mitigate ischemia-induced oligodendrocyte damage: potential roles of oligodendrogenesis, VEGF, and anti-inflammation.

Authors:  Hyeon Ju Kim; De-Maw Chuang
Journal:  Am J Transl Res       Date:  2014-05-15       Impact factor: 4.060

9.  Pathological effects of obstructive apneas during the sleep cycle in an animal model of cerebral small vessel disease.

Authors:  Eric E Lloyd; David J Durgan; Sharyl R Martini; Robert M Bryan
Journal:  Hypertension       Date:  2015-08-10       Impact factor: 10.190

10.  Tissue oxygen is reduced in white matter of spontaneously hypertensive-stroke prone rats: a longitudinal study with electron paramagnetic resonance.

Authors:  John Weaver; Fakhreya Y Jalal; Yi Yang; Jeffrey Thompson; Gary A Rosenberg; Ke J Liu
Journal:  J Cereb Blood Flow Metab       Date:  2014-02-19       Impact factor: 6.200

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.